Mirk/Dyrk1B modulates the development of chemoresistance in human ovarian cancer.

被引：0
|
作者：
Gao, Jingchun [1 ]
Li, Ji [1 ]
Gao, Heli [2 ]
Tian, Jianxin [1 ]
Lv, Yunyi [1 ]
Yang, Zhihai [1 ]
Zhang, Qiuping [2 ]
Kong, Fandou [1 ]
Pang, Jian [1 ]
Guan, Hongwei [2 ]
Shi, Hong [1 ]
机构：
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Dalian, Liaoning, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian, Liaoning, Peoples R China
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3376
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The kinase Mirk/Dyrk1b is activated through the Rac1-Mkk3 pathway and mediates survival in pancreatic ductal adenocarcinoma
    Deng, Xiaobing
    Jin, Kideok
    Ewton, Daina Z.
    Li, Sheena
    Naqvi, Asghar
    Mercer, Stephen E.
    Friedman, Eileen A.
    GASTROENTEROLOGY, 2006, 130 (04) : A36 - A36
  • [42] DYRK1B haploinsufficiency in a Holstein cattle with epilepsy
    Jacinto, Joana G. P.
    Bolcato, Marilena
    Haefliger, Irene M.
    Oevermann, Anna
    Gentile, Arcangelo
    Droegemueller, Cord
    ANIMAL GENETICS, 2023, 54 (05) : 623 - 627
  • [43] 3D multicellular pancreatic cancer spheroids as drug screening tool for pharmacological evaluation of EHT 5372 and other Mirk/DYRK1B inhibitors
    Casagrande, Anne-Sophie
    Bachelot, Florence
    Throo, Emeline
    Mahe, Florence
    Leblond, Bertrand
    Besson, Thierry
    Pando, Matthew
    Desire, Laurent
    CANCER RESEARCH, 2014, 74 (19)
  • [44] Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells
    Gao, Jingchun
    Zhao, Yi
    Lv, Yunyi
    Chen, Yamin
    Wei, Bing
    Tian, Jianxin
    Yang, Zhihai
    Kong, Fandou
    Pang, Jian
    Liu, Jiwei
    Shi, Hong
    CANCER CELL INTERNATIONAL, 2013, 13
  • [45] Implication of DYRK1B kinase in dormant glioblastoma cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for glioblastoma.
    Vilenchik, Maria
    Kuznetsova, Alexandra
    Frid, Michael
    Duey, Menelik
    Damiani, Arianna
    De Leon, Lita
    Law, Jason
    Golbin, Denis A.
    Shishkina, Ludmila V.
    Potapova, Olga
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells
    Jingchun Gao
    Yi Zhao
    Yunyi Lv
    Yamin Chen
    Bing Wei
    Jianxin Tian
    Zhihai Yang
    Fandou Kong
    Jian Pang
    Jiwei Liu
    Hong Shi
    Cancer Cell International, 13
  • [47] The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G0 by Mirk/dyrk1B kinase
    Deng, XB
    Mercer, SE
    Shah, S
    Ewton, DZ
    Friedman, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22498 - 22504
  • [48] Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases
    Leder, S
    Weber, Y
    Altafaj, X
    Estivill, X
    Joost, HG
    Becker, W
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (02) : 474 - 479
  • [49] A safe haven for cancer cells: tumor plus stroma control by DYRK1B
    Ems, Miriam
    Brichkina, Anna
    Lauth, Matthias
    ONCOGENE, 2025, 44 (06) : 341 - 347
  • [50] Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
    Marco Papenfuss
    Svenja Lützow
    Gerrit Wilms
    Aaron Babendreyer
    Maren Flaßhoff
    Conrad Kunick
    Walter Becker
    Scientific Reports, 12
12345